|Mary-Jo Murphy, MS, RN, CDE, certified diabetes educator||
For the past eight years, AACR has been the proud scientific partner to Stand Up To Cancer (SU2C), the groundbreaking initiative that galvanizes the power of Hollywood to fund cutting-edge translational cancer research. Last month, SU2C-affiliated scientists came together in Santa Monica, California, for the sixth annual SU2C Scientific Summit to report on and hear about recent progress made by the multi-institutional translational and clinical research “Dream Teams” that are the core of SU2C’s grant program, as well other members of the SU2C scientific community. As part of its expert scientific oversight and grants administration for SU2C, AACR organized and ran the two and a half day meeting. Attendees, including most of the SU2C Scientific Advisory Committee members, discussed the newest research and latest clinical trials in areas such as immunotherapy, precision medicine, and early detection and prevention in a focused, sometimes intense, and highly interactive atmosphere.
I was honored to attend as the Patient Advocate with the HPV team from Dana Farber Cancer Institute. We are living in a time of great hope because of the SU2C and its partnership with AACR.
Mary-Jo offers sage advice.